Science to Market

"Science to Market"
October 7 – 8, 2008
Convention Center, Hannover, Germany

The Workshop opens on Tuesday, October 7, 2008, at 08:30 and it closes on Wednesday, October 8, 2008, at 15:00.

Scope & Aim

As a European event the "Science to Market" EAPB conference aims at the promotion of partnering between the academic/ research community and the biotech and pharmaceutical industry.

The goal is to enhance the economical output of scientific results and turn them into marketable technologies and biopharmaceutical products. Therefore, academic research scientists from universities and research institutions as well as representatives of the biotech and pharmaceutical industry are invited to exchange ideas, finally leading to fruitful co-operations.

This conference will cover a broad spectrum of topics in the fields of biopharmaceutical drug development and novel biotechnological approaches.

Conference Workshops

The conference is separated into two workshops, both of it offers a plenary lecture, three sessions and three oral poster presentations. Workshop 1 focuses on "Therapeutics and diagnostics" and workshop 2 will discuss the topic "Novel technologies".

Poster Contributions

Poster presentations on scientific pharmaceutical drug projects and novel technologies in the fields of biotechnology and pharmaceutical drug development are welcome. The posters shall be presented by oral five-minutes-presentations (two slides on science and business opportunity) and in addition by traditional poster to facilitate networking between academic/ research and industrial partners.

Workshop 1: "Therapeutics and diagnostics"
(1a) Novel biopharmaceuticals and diagnostics
(1b) 2nd generation biopharmaceuticals
(1c) Novel vaccines and gene therapy developments

Workshop 2: "Novel technologies"
(2a) Novel biopharmaceutical drug formats
(2b) Novel Up-and Downstream developments
(2c) Novel biopharmaceutical drug delivery and analytical tools

For more information and for registration to this workshop, please visit the EAPB homepage under www.eapb.org/science_to_market_08/science_to_market_08.html

Registration is now open: http://www.biotechnica.de/50919
Download: www.efb-central.org/images/2ndAnnouncementScienceToMarket.pdf

Please also consider sponsoring options.

With kind regards,
Wieland W. Wolf
President of EAPB
The officially associated section of Pharma & Medical Biotechnology of EFB